TrialGut2025

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.

Javier P Gisbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.